Methylation of the PD-L1 promoter has been found to be negatively correlated with its mRNA and protein expression in various cancers such as gastric cancer [188], diffuse low-grade glioma [189], and non-small cell lung cancer [190]. Here, CD274 is linked to non-small cell lung carcinoma.